Gene · 3635
Papers3,499
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,499
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Endoplasmic Reticulum Stress-Induced triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Downregulation Exacerbates Platelet Activation and Myocardial Infarction in Patients With Coronary Artery Disease. | J Am Heart Assoc | 2025 | 40551335 | PubTator, text mining | PubMed |
| Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma. | Clin Cancer Res | 2025 | 40392969 | PubTator, text mining | PubMed |
| TIGIT deficiency promotes autoreactive CD4+ T-cell responses through a metabolic‒epigenetic mechanism in autoimmune myositis. | Nat Commun | 2025 | 40374622 | PubTator, text mining | PubMed |
| KLRG1 expression induces functional exhaustion of NK cells in colorectal cancer patients. | Cancer Immunol Immunother | 2025 | 40372495 | PubTator, text mining | PubMed |
| Protective Genes Against Alzheimer's Disease: Case Review and Therapeutic Implications. | Dement Neurocogn Disord | 2025 | 40321438 | PubTator, text mining | PubMed |
| Semantic enrichment of Pomeranian health study data using LOINC and WHO-FIC terminology mapping principles. | JAMIA Open | 2025 | 40059976 | PubTator, text mining | PubMed |
| ICEEMDAN-RPE-AITD algorithm for magnetic field signals of magnetic targets. | Sci Rep | 2025 | 39987193 | PubTator, text mining | PubMed |
| A microRNA-regulated transcriptional state defines intratumoral CD8+ T cells that respond to immunotherapy. | Cell Rep | 2025 | 39951377 | PubTator, text mining | PubMed |
| Imaging of biphasic signalosomes constructed by checkpoint receptor 2B4 in conventional and chimeric antigen receptor-T cells. | iScience | 2025 | 39886466 | PubTator, text mining | PubMed |
| Amelioration of premature aging in Werner syndrome stem cells by targeting SHIP/AKT pathway. | Cell Biosci | 2025 | 39863890 | PubTator, text mining | PubMed |
| Functional Characterization of the SHIP1-Domains Regarding Their Contribution to Inositol 5-Phosphatase Activity. | Biomolecules | 2025 | 39858499 | PubTator, text mining | PubMed |
| Aminocholestane and Aminoandrostane Inhibitors of the SH2 Domain-Containing Inositol 5'-Phosphatase (SHIP). | ChemMedChem | 2025 | 39843392 | PubTator, text mining | PubMed |
| Macrophage to neuron communication via extracellular vesicles in neuropathic pain conditions. | Heliyon | 2025 | 39811367 | PubTator, text mining | PubMed |
| Single-nucleus transcriptome profiling provides insights into the pathophysiology of adhesive arachnoiditis. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39755217 | PubTator, text mining | PubMed |
| SHIP-1 Differentially Regulates IgE-Induced IL-10 and Antiviral Responses in Human Monocytes. | Eur J Immunol | 2025 | 39668409 | PubTator, text mining | PubMed |
| Microglial lipid phosphatase SHIP1 limits complement-mediated synaptic pruning in the healthy developing hippocampus. | Immunity | 2025 | 39657671 | PubTator, text mining | PubMed |
| Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease. | Alzheimers Dement | 2025 | 39641322 | PubTator, text mining | PubMed |
| Correction to "AQX-1125, small molecule SHIP1 activator inhibits bleomycin-induced pulmonary fibrosis". | Br J Pharmacol | 2025 | 39627028 | PubTator, text mining | PubMed |
| Deficiency of miR-155 in Leukemic B-Cells Results in Cell Cycle Arrest and Deregulation of MIR155HG/TP53INP1/CDKN1A/CCND1 network. | Arch Med Res | 2025 | 39591901 | PubTator, text mining | PubMed |
| [Analysis of PIKFYVE gene expression, clinical significance, and experimental validation based on TCGA database in hepatocellular carcinoma]. | Zhonghua Gan Zang Bing Za Zhi | 2025 | 39528312 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3635/papers?page=5